Journal article
Clinical neurological studies in Germany - An update
Aktuelle Neurologie, v 33(9), pp 492-496
01 Nov 2006
Abstract
In January 2006, the German Neurological Society organized an update meeting to discuss current aspects of clinical neurological studies in Germany. The 12(th) Amendment of the German pharmaceutical law that came into effect in August 2004 and its implications for conducting clinical studies were discussed by neurologists, members of ethical committees, the pharmaceutical industry and federal institutions. Overall, the performance of industry-sponsored clinical trials has been facilitated by changes in the German pharmaceutical law, whereas some modifications regarding legal and financial aspects will make future investigator-sponsored trials more difficult. This article summarizes the lectures from this meeting and presents an update on clinical neurological studies in Germany.
Metrics
11 Record Views
Details
- Title
- Clinical neurological studies in Germany - An update
- Creators
- R. WeberJ. BenemannH. -C. DienerAutorengrp
- Publication Details
- Aktuelle Neurologie, v 33(9), pp 492-496
- Publisher
- Thieme Medical Publishers
- Number of pages
- 7
- Resource Type
- Journal article
- Language
- German
- Academic Unit
- Information Science
- Web of Science ID
- WOS:000242491700005
- Scopus ID
- 2-s2.0-33845200381
- Other Identifier
- 991019238536604721
InCites Highlights
Data related to this publication, from InCites Benchmarking & Analytics tool:
- Web of Science research areas
- Clinical Neurology